Clinical Trials Browser

Interventional × Primary Condition: Advanced Tumors × toripalimab × Clear all

NCT05650203 2023-04-05

A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies

Phase 1 Withdrawn

Primary Condition: Advanced Tumors